테네시의 혈액암 임상 시험
혈액암 관련 연구 20개가 테네시 내 여러 지역에서 참여자를 모집하고 있습니다.
테네시의 도시
공식 연구 텍스트(영어)
Long-term Safety and Efficacy Extension Study for Participants With Advanced Tumors Who Are Currently on Treatment or in Follow-up in a Pembrolizumab (MK-3475) Study (MK-3475-587/KEYNOTE-587)
- Vanderbilt Health One Hundred Oaks Diagnostic ( Site 0060), Nashville
- Vanderbilt University Medical Center-Vanderbilt-Ingram Cancer Center ( Site 0015), Nashville
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 11. 13. 업데이트됨 · NCT03486873Studies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With Untreated NPM1-m or KMT2A-r AML
- Baptist Clinical Research Institute, Memphis
- Tennessee Oncology, Nashville
- TriStar Centennial Medical Center, Nashville
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 11. 12. 업데이트됨 · NCT07007312Prospective Evaluation Of Delayed Effects Of Pediatric Car T Cell Therapy
- St. Jude Children's Research Hospital, Memphis
피험자 모집 중관찰 연구
30세 이하 · 모든 성별 · 2026. 11. 4. 업데이트됨 · NCT06579469A Study of JNJ-95804306 for Relapsed or Refractory Hematological Malignancies
- Sarah Cannon Cancer Institute, Nashville
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 11. 3. 업데이트됨 · NCT07572006Pivotal Open-label Phase 3 Clinical Study of QTX-2101 in Adult Patients With Acute Promyelocytic Leukemia
- Sarah Cannon Research Institute at TriStar Centennial Medical Center, Nashville
피험자 모집 중3상
18세 ~ 71세 · 모든 성별 · 2026. 10. 30. 업데이트됨 · NCT07504458A Study to Evaluate INCA036873 in Participants With Advanced Solid Tumors and Hematological Malignancies
- Scri Oncology Partners, Nashville
- Vanderbilt Medical Center, Nashville
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 10. 9. 업데이트됨 · NCT07195916A Study of the Drug Letermovir as Prevention of Cytomegalovirus Infection After Stem Cell Transplant in Pediatric Patients
- The Children's Hospital at TriStar Centennial, Nashville
- Vanderbilt University/Ingram Cancer Center, Nashville
피험자 모집 중3상
2세 ~ 18세 · 모든 성별 · 2026. 10. 6. 업데이트됨 · NCT05711667CD45RA-depleted CD19-CAR T Cell Consolidation After TCRαβ+/CD19 B Cell-depleted Haploidentical Hematopoietic Cell Transplantation for Relapsed/Refractory CD19+ ALL and Lymphoma
- St. Jude Children's Research Hospital, Memphis
피험자 모집 중1상
21세 이하 · 모든 성별 · 2026. 8. 28. 업데이트됨 · NCT07257419Safety and Tolerability of Ziftomenib Combinations in Patients With Relapsed/Refractory Acute Myeloid Leukemia
- Vanderbilt University Medical Center, Nashville
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 8. 20. 업데이트됨 · NCT06001788A Phase 1 Study of IM-1021 in Participants With Advanced Cancer
- Sarah Cannon Research Institute - Oncology Partners, Nashville
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 8. 10. 업데이트됨 · NCT06823167Trial of Orca-T Following Reduced Intensity or Nonmyeloablative Conditioning in Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome
- Vanderbilt University, Ingram Cancer Center, Nashville
피험자 모집 중2상
18세 이상 · 모든 성별 · 2026. 7. 7. 업데이트됨 · NCT07216443A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
- St. Jude Childrens Research Hospital, Memphis
- Vanderbilt University, Nashville
피험자 모집 중관찰 연구
전 연령 · 모든 성별 · 2026. 7. 6. 업데이트됨 · NCT01351545Long-term Follow-up After Adoptive Transfer of Genetically Modified Cell Products
- St. Jude Children's Research Hospital, Memphis
피험자 모집 중관찰 연구
전 연령 · 모든 성별 · 2026. 6. 17. 업데이트됨 · NCT05713214Response to Influenza Vaccination in Pediatric Oncology Patients
- St. Jude Children's Research Hospital, Memphis
피험자 모집 중관찰 연구
18세 이하 · 모든 성별 · 2026. 6. 12. 업데이트됨 · NCT05384288TCRαβ-depleted Progenitor Cell Graft With Early Memory T-cell DLI, Plus Selected Use of Blinatumomab, in naïve T-cell Depleted Haploidentical Donor Hematopoietic Cell Transplantation for Hematologic Malignancies
- St. Jude Children's Research Hospital, Memphis
피험자 모집 중1상건강한 지원자 환영
21세 이하 · 모든 성별 · 2026. 6. 2. 업데이트됨 · NCT07052370A Study to Investigate the Safety and Tolerability of Ziftomenib in Combination With Venetoclax/Azacitidine, Venetoclax, 7+3, or 7+3+Quizartinib in Patients With AML
- TriStar Bone Marrow Transplant, Nashville
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 3. 13. 업데이트됨 · NCT05735184CAR T-cell Therapy Directed to CD70 for Pediatric Patients With Hematological Malignancies
- St. Jude Children's Research Hospital, Memphis
피험자 모집 중1상
21세 이하 · 모든 성별 · 2026. 1. 23. 업데이트됨 · NCT06326463IDP-023 as a Single Agent and in Combination With Antibody Therapies in Patients With Advanced Hematologic Cancers
- SCRI Oncology Partners, Nashville
피험자 모집 중1/2상
18세 이상 · 모든 성별 · 2025. 6. 3. 업데이트됨 · NCT06119685Tagraxofusp in Pediatric Patients With Relapsed or Refractory CD123 Expressing Hematologic Malignancies
- St. Jude Children's Research Hospital, Memphis
피험자 모집 중1상
1세 ~ 21세 · 모든 성별 · 2024. 12. 6. 업데이트됨 · NCT05476770Study of VIP943 in Subjects With Advanced CD123+ Hematologic Malignancies
- TriStar Bone Marrow Transplant, Nashville
피험자 모집 중1상
18세 이상 · 모든 성별 · 2024. 11. 15. 업데이트됨 · NCT06034275ClinicalTrials.gov 출처, 2026. 11. 15. 기준 데이터입니다. 각 연구는 자체적인 자격 기준을 설정하며, 연구 팀이 참여자를 결정합니다.